CustomSurg AG is a Zurich-based medical technology company commercializing an AI-powered surgical planning platform for complex fracture treatment. The company occupies a unique, regulatory-cleared position at the intersection of orthopaedic surgery, biomechanical simulation, and applied machine learning — a discipline that has remained almost entirely undigitized while adjacent fields such as hip, knee and spine surgery have undergone full digital transformation.
The company’s cleared commercial product, OrthoPlanner™, delivers an automated scan-to-plan service: surgeons upload routine CT imaging and receive a patient-specific, biomechanically validated surgical plan on their mobile device. The platform is FDA 510(k) cleared (K251863), CE Marked under MDR, ISO 13485 compliant, and MDSAP audited. It is commercially live across six fracture anatomies, with clinical cases now running daily across the United States and Europe.